Suppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments

BMC Research Notes

Volumn 2, Issue , 2009, Pages

  Wang, Bijue ^a   Chen, Pingping ^a   Jensen, Anne Christine ^b   Karsdal, Morten ^b   Madsen, Suzi ^b   Sondergaard, Bodil Cecilie ^b   Zheng, Qinlong ^a   Qvist, Per ^b  

^a Nordic Bioscience Beijing   (China)

^b NORDIC BIOSCIENCE A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINAE;

EID: 77049123522     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-2-259     Document Type: Article

References (30)

1. Drug delivery strategies for cathepsin inhibitors in joint diseases. Wang D Bromme D, Expert Opin Drug Deliv 2005 2 1015 28 10.1517/17425247.2.6.1015 16296806
2. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Little CB Flannery CR, Hughes CE Mort JS, Roughley PJ Dent C., et al. Biochem J 1999 344 61 8 10.1042/0264-6021: 3440061 10548534
3. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. Lark MW Bayne EK, Flanagan J Harper CF, Hoerrner LA Hutchinson NI., et al. J Clin Invest 1997 100 93 106 10.1172/JCI119526 9202061
4. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. Fosang AJ Last K Maciewicz RA., J Clin Invest 1996 98 2292 9 10.1172/JCI119040 8941646
5. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Karsdal MA Madsen SH, Christiansen C Henriksen K, Fosang AJ Sondergaard BC, Arthritis Res Ther 2008 10 63 10.1186/ar2434 18513402
6. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Sondergaard BC Henriksen K, Wulf H Oestergaard S, Schurigt U Brauer R., et al. Osteoarthritis Cartilage 2006 14 738 48 10.1016/j.joca.2006.01.016 16563811
7. A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Sandy JD, Osteoarthritis Cartilage 2006 14 95 100 10.1016/j.joca.2005.09.004 16257242
8. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Milner JM Rowan AD, Cawston TE Young DA, Arthritis Res Ther 2006 8 142 10.1186/ar2034 16919164
9. Cartilage formation measured by a novel PIINP assay suggests that IGF-I does not stimulate but maintains cartilage formation ex vivo. Madsen SH Sondergaard BC, Jensen AC Karsdal MA, Scand J Rheumatol 2009 1 5
10. Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M. Durigova M Roughley PJ Mort JS., Osteoarthritis Cartilage 2008 16 98 104 10.1016/j.joca.2007.05.002 17574450
11. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants. Stevens AL Wheeler CA, Tannenbaum SR Grodzinsky AJ, Osteoarthritis Cartilage 2008 16 489 97 10.1016/j.joca.2007.07.015 17923423
12. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Hui W Rowan AD, Richards CD Cawston TE, Arthritis Rheum 2003 48 3404 18 10.1002/art.11333 14673992
13. Interleukin-1alpha induction of tensile weakening associated with collagen degradation in bovine articular cartilage. Temple MM Xue Y, Chen MQ Sah RL, Arthritis Rheum 2006 54 3267 76 10.1002/art.22145 17009261
14. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes. Shingleton WD Jones D Xu X Cawston TE, Rowan AD., Rheumatology (Oxford) 2006 45 958 65 10.1093/rheumatology/kel024 16467367
15. Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage. Lin PM Chen CT Torzilli PA., Osteoarthritis Cartilage 2004 12 485 96 10.1016/j.joca.2004.02. 012 15135145
16. MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays. Sumer EU Sondergaard BC, Rousseau JC Delmas PD, Fosang AJ Karsdal MA., et al. Osteoarthritis Cartilage 2007 15 212 21 10.1016/j.joca.2006.07.009 16997584
17. The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseases. Oestergaard S Chouinard L, Doyle N Karsdal MA, Smith SY Qvist P., et al. Osteoarthritis and Cartilage 2006 14 370 9 10.1016/j.joca.2006.01.004 (Pubitemid 43842730)
18. Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation. Karsdal MA Sumer EU, Wulf H Madsen SH, Christiansen C Fosang AJ., et al. Arthritis Rheum 2007 56 1549 58 10.1002/art.22599 17469134
19. Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants. Fosang AJ Last K, Stanton H Weeks DB, Campbell IK Hardingham TE., et al. J Biol Chem 2000 275 33027 37 10.1074/jbc.M910207199 10882746
20. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. Sandy JD Flannery CR, Neame PJ Lohmander LS, J Clin Invest 1992 89 1512 6 10.1172/JCI115742 1569188
21. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). Fosang AJ Last K Knauper V Murphy G, Neame PJ., FEBS Lett 1996 380 17 20 10.1016/0014-5793(95)01539-6 8603731
22. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. Flannery CR Lark MW Sandy JD., J Biol Chem 1992 267 2 1008 14 1730630
23. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase-and matrix metalloproteinase-generated aggrecan fragments. Struglics A Larsson S, Pratta MA Kumar S, Lark MW Lohmander LS, Osteoarthritis Cartilage 2006 14 101 13 10.1016/j.joca.2005.07.018 16188468
24. Structure and interactions of cartilage proteoglycan binding region and link protein. Bonnet F Dunham DG Hardingham TE., Biochem J 1985 228 77 85 4004817 (Pubitemid 15050251)
25. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments. Pratta MA Su JL, Leesnitzer MA Struglics A, Larsson S Lohmander LS., et al. Osteoarthritis Cartilage 2006 14 702 13 10.1016/j.joca.2006.01.012 16549371
26. Development and characterization of a novel ELISA based assay for the quantitation of sub-nanomolar levels of neoepitope exposed NITEGE-containing aggrecan fragments. Carter QL Dotzlaf J, Swearingen C Brittain I, Chambers M Duffin K., et al. J Immunol Methods 2007 328 162 8 10.1016/j.jim.2007.08.018 17942111
27. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain. Oshita H Sandy JD Suzuki K Akaike A, Bai Y Sasaki T, Shimizu K., Biochem J 2004 382 Pt 1 253 9 15175011
28. Aggrecanases and cartilage matrix degradation. Nagase H Kashiwagi M, Arthritis Res Ther 2003 5 94 103 10.1186/ar630 12718749
29. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). Hashimoto G Aoki T Nakamura H Tanzawa K, Okada Y., FEBS Lett 2001 494 192 5 10.1016/S0014-5793(01)02323-7 11311239
30. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). Kashiwagi M Tortorella M, Nagase H Brew K, J Biol Chem 2001 276 12501 4 10.1074/jbc.C000848200 11278243